Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
about
Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver DiseaseTotal kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease.Hepatocystin is Essential for TRPM7 Function During Early Embryogenesis.Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease.Lin28 and let-7: roles and regulation in liver diseases.Pediatric living donor liver transplantation for congenital hepatic fibrosis using a mother's graft with von Meyenburg complex: A case report.Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.Polycystic Liver Disease and Sarcoidosis: Unusual Coexisting Etiologies of Portal Hypertension.Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.Therapeutic Targets in Polycystic Liver Disease.Surgery is the preferred treatment for bile duct hamartomas.Adult polycystic liver disease concomitant with severe anemia due to intracystic bleeding is an indication for liver transplantation: case report and review of literature.Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial.Starry Liver: An Unexpected Diagnosis.TGR5 in the Cholangiociliopathies.Hepatorenal fibrocystic diseases in children.Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches.Weight loss in a patient with polycystic kidney disease: when liver cysts are no longer innocent bystanders.Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.The combination of an HDAC6 inhibitor and a somatostatin receptor agonist synergistically reduces hepato-renal cystogenesis in an animal model of polycystic liver disease.Isolated Polycystic Liver Disease: An Unusual Cause of Recurrent Variceal Bleed.Cholangiopathies - Towards a molecular understanding
P2860
Q34529587-72C3A1B1-1E39-44C7-A42F-267394A41C47Q36249832-C2B69C08-0C18-4697-8E8D-854C1020AFD1Q36376131-55F3319B-5FC8-4EAF-8D33-9003FED4BBD8Q36753925-E92034DF-559C-4639-806D-A60FE05F4D70Q36955306-C58E658C-5A0B-4395-B54E-EBD7220B050EQ37444299-89016241-5CFE-45C4-B6FF-FCDFB60A48B1Q37620079-571A5C16-BD1E-43F4-9001-1432322DFAE6Q37666139-FA81142C-1C4E-4660-8EE1-B515A5F6F3EAQ38255110-C479C2FC-7CFB-4AB4-9CBB-BDED1A25B68EQ38443908-45C1B02D-5EB6-4FEB-BAEF-01F4EEF339F4Q38601380-6590FF13-CF94-442F-9E02-29D66C130A49Q38761863-401929DF-AFA2-426F-A26F-F0D1F2DED959Q38906055-2B961EAB-5912-45B5-8774-4E88334F7F83Q39199053-24DD4363-9B89-477D-90B8-4283F45F0B96Q40779287-F35D39F9-D597-488E-884B-0BA5857E801CQ40867711-717EC317-5F9D-4343-B60F-7FDD72E7309AQ41496131-B6BD76D4-C759-4334-8ABE-23333E64DE57Q42347559-03B99C51-3A83-447F-B3F8-3B02B5CB0B6EQ47394138-E324BDBE-CD09-46E3-BE42-237DBD0C6D24Q47706205-0F08D372-C265-4C5D-8FE1-FA3978B19CDFQ47781166-05D2DE3F-3FC3-4459-95A5-2F31F9C19D58Q49795322-0371A178-6755-4756-BDF0-7D8816E38258Q55406157-417D8917-5C0A-4E59-A2AA-F09806095A6BQ57109524-B11D7D7A-5DE4-46C6-B664-27DC30F59811
P2860
Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polycystic liver disease: an o ...... manifestations and management.
@ast
Polycystic liver disease: an o ...... manifestations and management.
@en
type
label
Polycystic liver disease: an o ...... manifestations and management.
@ast
Polycystic liver disease: an o ...... manifestations and management.
@en
prefLabel
Polycystic liver disease: an o ...... manifestations and management.
@ast
Polycystic liver disease: an o ...... manifestations and management.
@en
P2860
P356
P1476
Polycystic liver disease: an o ...... manifestations and management.
@en
P2093
Joost P H Drenth
Wybrich R Cnossen
P2860
P2888
P356
10.1186/1750-1172-9-69
P5008
P577
2014-05-01T00:00:00Z
P5875
P6179
1014253084